Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Conatus Pharmaceuticals: What Investors Can Expect From This Interesting NASH Innovator? [Seeking Alpha]

CONATUS PHARMACEUTICALS INC (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations
Company Research Source: Seeking Alpha
Conatus Pharmaceuticals: What Investors Can Expect From This Interesting NASH Innovator?SummaryConatus Pharmaceuticals is a strong grower to potentially tap into the lucrative nonalcoholic steatohepatitis market.Phase 2B POLT-HCV-SVR trial recently reported unfavorable results. Nevertheless, the subpopulation analysis revealed that (emricasan) showed antifibrotic effects.The aforementioned drug is currently being assessed in three additional phase 2B (ENCORE) trials. Outcomes of the ENCORE studies can either catapult the stock to a new high or decimate.Company is expanding its pipeline to target other therapeutic areas to give more "shots on goal" of finding a blockbuster.This is a sample of the Integrated BioSci Research that we made available in advance and exclusive to our subscribers. Show less Read more
Impact Snapshot
Event Time:
CNAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CNAT alerts
Opt-in for
CNAT alerts

from News Quantified
Opt-in for
CNAT alerts

from News Quantified